Opinion | Controlling the control arm in metastatic castration-resistant prostate cancer trials: best standard of care or the minimum standard of care? 23 Feb, 2022 | 10:03h | UTC Controlling the Control Arm in Metastatic Castration-Resistant Prostate Cancer Trials: Best Standard of Care or the Minimum Standard of Care? – Journal of Clinical Oncology